-
Featured Authors
Archive
- April 2013 (1)
- February 2013 (4)
- January 2013 (2)
- December 2012 (1)
- November 2012 (2)
- October 2012 (2)
- August 2012 (1)
- July 2012 (2)
- June 2012 (2)
- May 2012 (1)
- April 2012 (1)
- March 2012 (1)
- December 2011 (1)
- August 2011 (2)
- July 2011 (1)
- June 2011 (5)
- May 2011 (1)
- March 2011 (1)
- February 2011 (1)
- January 2011 (2)
- December 2010 (1)
- November 2010 (2)
- October 2010 (1)
- September 2010 (1)
- August 2010 (1)
- July 2010 (2)
- May 2010 (1)
- April 2010 (1)
- March 2010 (2)
- February 2010 (6)
- January 2010 (1)
- November 2009 (2)
- October 2009 (2)
- September 2009 (1)
- August 2009 (2)
- July 2009 (3)
- June 2009 (2)
- May 2009 (6)
- March 2009 (1)
Category Archives: Jim’s Corner
Telling the Biotech Story at the BIO International Convention
The global event for biotechnology wrapped up last week at the Boston Convention & Exhibition Center in Boston, Mass. The event was a huge success, with a record 25,291 partnering meetings and hundreds of high-level speakers addressing critical global challenges and opportunities. More than 16,500 industry leaders from 49 states and 65 countries attended, yet again earning the title as the largest biotechnology event in the world. People are always asking for my perspective on our Convention, Read More >
We Are BIO
Here’s what the Biotechnology Industry Organization is doing for you. This year, we challenged you to answer the question – What’s Your BIO? On behalf of the Biotechnology Industry Organization (BIO), I’d like to answer that question to illustrate how we advocate for federal, state and global policies to foster continued biotech breakthroughs, innovation and ingenuity. In addition to producing the BIO International Convention, we educate and engage public policy leaders in Washington, in state Read More >
Jim's Corner
Leave a comment
Email This Post
Tags: 2012 BIO International Convention, agricultural biotechnology, agriculture, BIO International Convention, business development, Health Care, International, PDUFA, prescription drugs, public policy, reimbursment, sbir, small business, TDP, Therapeutic Discovery Project
Tags: 2012 BIO International Convention, agricultural biotechnology, agriculture, BIO International Convention, business development, Health Care, International, PDUFA, prescription drugs, public policy, reimbursment, sbir, small business, TDP, Therapeutic Discovery Project
2012 BIO International Convention Keynotes: Back to Basics
The 2012 BIO International Convention is a few short weeks away, and we are looking forward to this opportunity to come together for connections and partnerships that will lead to tomorrow’s breakthroughs. The Keynote Luncheon panels are always a highlight of the Convention. This year in Boston we decided to focus on core issues facing the global biotech community with keynote speakers and panelists who will provide timely insights on the economic, policy and business Read More >
National Bioeconomy Blueprint
Today, the White House released its National Bioeconomy Blueprint. The Blueprint defines the bioeconomy as, “economic activity that is fueled by research and innovation in the biological sciences” and identifies the bioeconomy as a priority for the Obama Administration. BIO provided input and submitted ideas to the Administration after it announced the development of the Blueprint last Fall. While the Administration has largely been focused on advancing innovation in areas such as electronic devices, social Read More >
Bringing Hope to Patients
No-one expected Hope Bartley to survive after she was born three months early. Thanks to extraordinary biotech medicine, she did. Alena Galan, age 14, is one of only a few thousand patients with a rare disease called MPS. Thanks to the hard work of leading biotech scientists and the approval of a new treatment, she now has a chance to lead a normal life. Lori Lober experienced the unthinkable when she was diagnosed with Stage Read More >
